Recap: Atea Pharmaceuticals Q2 Earnings

Loading...
Loading...

 

Atea Pharmaceuticals AVIR reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Atea Pharmaceuticals beat estimated earnings by 26.92%, reporting an EPS of $-0.38 versus an estimate of $-0.52.

Revenue was down $60.39 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 2.73% increase in the share price the next day.

 

To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...